secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2026-06-17T20:05:45+00:00
Accession:  0001193125-26-274139
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve amendment to 2025 Equity Incentive Plan, adding 850,000 shares
--------------------------------------------------------------------------------

- Amendment increases authorized shares by 850,000; includes convertible preferred and pre-funded warrants in annual auto-increase calculation.
- Holders elect David P. Bonita, M.D. and Joseph P. Slattery as Class II directors for term until 2029.
- Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year 2026.
- All proposals approved with over 84% of votes cast in favor for each (excluding broker non-votes).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312526274139/0001193125-26-274139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312526274139/d114862d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-274139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer